Daniel Lynch

Insider Reports History

Entity: Individual
Signature: /s/ Francis I. Perier, Jr. as Attorney-in Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
SpringWorks Therapeutics, Inc.	Director	Common Stock	82.9K	$5.08M	$61.24	Feb 20, 2025	Direct
2seventy bio, Inc.	Director	Common Stock	21.1K	$79K	$3.75	Jun 13, 2023	Direct
2seventy bio, Inc.	Director	Stock Option (right to buy)	16.9K	$66.4K	$3.93	Jun 13, 2023	Direct
bluebird bio, Inc.	Director	Common Stock	7.96K	$11.4K	$1.43	Nov 11, 2021	Direct
SpringWorks Therapeutics, Inc.	Director	Stock Option (Right to Buy)	12.2K			May 16, 2024	Direct
bluebird bio, Inc.	Director	Stock Option (right to buy)	0			Nov 11, 2021	Direct

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
SWTX	SpringWorks Therapeutics, Inc.	Feb 20, 2025	2	-$2.87M	4	Feb 24, 2025	Director
SWTX	SpringWorks Therapeutics, Inc.	Feb 14, 2025	1	-$24K	4	Feb 19, 2025	Director
SWTX	SpringWorks Therapeutics, Inc.	Feb 10, 2025	3	-$9.53M	4	Feb 12, 2025	Director
SWTX	SpringWorks Therapeutics, Inc.	May 16, 2024	2	$0	4	May 17, 2024	Director
TSVT	2seventy bio, Inc.	Jun 13, 2023	2	$0	4	Jun 15, 2023	Director
SWTX	SpringWorks Therapeutics, Inc.	May 24, 2023	2	$0	4	May 25, 2023	Director
TSVT	2seventy bio, Inc.	Jun 8, 2022	2	$0	4	Jun 9, 2022	Director
SWTX	SpringWorks Therapeutics, Inc.	May 19, 2022	2	$0	4	May 20, 2022	Director
BLUE	bluebird bio, Inc.	Nov 11, 2021	10	$0	4	Nov 17, 2021	Director
TSVT	2seventy bio, Inc.	Nov 11, 2021	10	$0	4	Nov 16, 2021	Director
XLO	Xilio Therapeutics, Inc.	Oct 21, 2021	0	$0	3	Oct 21, 2021	Director, 10%+ Owner
TSVT	2seventy bio, Inc.	Oct 18, 2021	0	$0	3	Oct 18, 2021	Director
BLUE	bluebird bio, Inc.	Jun 15, 2021	2	$0	4	Jun 17, 2021	Director
SWTX	SpringWorks Therapeutics, Inc.	May 20, 2021	2	$0	4	May 21, 2021	Director